thyroxine has been researched along with Atrial Fibrillation in 97 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This is a substudy of a prospective randomized controlled trial (SAFE-Trial) in which amiodarone, sotalol, and placebo for persistent atrial fibrillation were evaluated." | 9.12 | Thyroid function abnormalities during amiodarone therapy for persistent atrial fibrillation. ( Batcher, EL; Hershman, JM; Reda, DJ; Singh, BN; Singh, SN; Tang, XC, 2007) |
| "Contemporary data on the effect of levothyroxine dose on the occurrence of atrial fibrillation (AF) are lacking, particularly in the older population." | 8.02 | Levothyroxine dose and risk of atrial fibrillation: A nested case-control study. ( Atzema, CL; Austin, PC; Gong, IY; Lega, IC; Lipscombe, LL; Na, Y; Rochon, PA, 2021) |
| "Levothyroxine treatment is common among older adults as is atrial fibrillation (AF), yet less is known about its potential effects on the development of dementia." | 7.96 | Levothyroxine treatment and incident dementia in adults with atrial fibrillation. ( Carlsson, AC; Li, X; Sundquist, J; Sundquist, K; Wändell, P, 2020) |
| "The possible adverse or positive effects of levothyroxine treatment among patients with atrial fibrillation have been debated." | 7.91 | Effect of Levothyroxine Treatment on Incident Dementia in Adults with Atrial Fibrillation and Hypothyroidism. ( Carlsson, AC; Sundquist, J; Sundquist, K; Wändell, P, 2019) |
| "We describe the effects of iopanoic acid on daily levels of free triiodothyronine (FT(3)) and free thyroxine (FT(4)) in a patient with progressive type II amiodarone-induced thyrotoxicosis (AIT) who was undergoing thyroidectomy." | 7.74 | Pharmacodynamic effect of iopanoic acid on free T(3) and T(4) levels in amiodarone-induced thyrotoxicosis. ( Falciglia, M; Matrka, L; Nikiforov, Y; Steward, D, 2008) |
| " Sixteen patients (89%) developed hypothyroidism requiring replacement therapy with L-thyroxine." | 7.72 | [Prevention of recurrent amiodarone-induced hyperthyroidism by iodine-131]. ( Arlot, S; Hermida, JS; Jarry, G; Moullart, V; Rey, JL; Schvartz, C; Tcheng, E, 2004) |
| "Twenty patients with thyrotoxic Basedow's disease complicated by atrial fibrillation lasting more than one month despite treatment with antithyroidal drugs were treated with radioiodine supplemented with an antithyroidal drug or inorganic iodine." | 7.68 | Reversion of thyrotoxic atrial fibrillation in hypothyroid state after radioiodine treatment. ( Fukazawa, H; Itagaki, Y; Kaise, K; Kaise, N; Saito, S; Sakurada, T; Yamamoto, M; Yoshida, K; Yoshinaga, K, 1992) |
| "In patients with newly treated hypothyroidism, cardiovascular event rates were similar for generic and brand L-T4." | 5.51 | Comparison of Incident Cardiovascular Event Rates Between Generic and Brand l-Thyroxine for the Treatment of Hypothyroidism. ( Bernet, V; Kusumoto, F; Mwangi, R; Sangaralingham, LR; Smallridge, RC; Van Houten, H, 2019) |
| " Subclinical hypothyroidism is diagnosed by elevated serum levels of thyroid-stimulating hormone (TSH) with thyroxine levels within the reference range, and subclinical hyperthyroidism is diagnosed by low TSH in conjunction with thyroxine and triiodothyronine levels within reference ranges." | 5.12 | Challenges in the Management of Atrial Fibrillation With Subclinical Hyperthyroidism. ( Cappola, AR; Collet, TH; Gencer, B; Rodondi, N, 2021) |
| "This is a substudy of a prospective randomized controlled trial (SAFE-Trial) in which amiodarone, sotalol, and placebo for persistent atrial fibrillation were evaluated." | 5.12 | Thyroid function abnormalities during amiodarone therapy for persistent atrial fibrillation. ( Batcher, EL; Hershman, JM; Reda, DJ; Singh, BN; Singh, SN; Tang, XC, 2007) |
| "To analyse the efficiency of thyroid function tests (thyroid stimulating hormone, thyroxine and tri-iodothyronine) on prediction of postoperative atrial fibrillation." | 5.05 | Efficiency of Thyroid Function Test in the Prediction of Atrial Fibrillation Following Open Heart Surgery. ( Kayacioglu, I; Özdemir, K; Öztürk, I; Öztürk, S; Sensoz, Y, 2020) |
| "Reports published with the following search terms were searched:, thyroid, hypothyroidism, hyperthyroidism, subclinical hyperthyroidism, subclinical hypothyroidism, levothyroxine, triiodothyronine, antithyroid drugs, radioiodine, deiodinases, clinical symptoms, heart rate, HF, systolic function, diastolic function, systemic vascular resistance, endothelial function, amiodarone and atrial fibrillation." | 4.88 | Mechanisms in endocrinology: Heart failure and thyroid dysfunction. ( Biondi, B, 2012) |
| " Amiodarone-induced hypothyroidism (AIH) does not pose relevant problems, is easily controlled by L-thyroxine replacement, and does not require amiodarone withdrawal." | 4.88 | Amiodarone and the thyroid: a 2012 update. ( Aghini-Lombardi, F; Bartalena, L; Bogazzi, F; Martino, E; Tomisti, L, 2012) |
| "An 88-year-old female, living independently in the community, developed duodenal and gastric ulcers from using overthe-counter naproxen sodium for pain related to a shoulder fracture and arthritis of the knees." | 4.88 | Gastrointestinal bleeding and possible hypothyroidism. ( Marshall, LL, 2012) |
| "Subclinical hyperthyroidism is defined by low or undetectable serum thyroid-stimulating hormone levels, with normal free thyroxine and total or free triiodothyronine levels." | 4.87 | Update on subclinical hyperthyroidism. ( Braunstein, GD; Donangelo, I, 2011) |
| "Patients with differentiated thyroid carcinoma are commonly treated long-term with thyrotropin (TSH)-suppressive thyroxine replacement therapy, which lead to a state of subclinical hyperthyroidism." | 4.84 | [Effects of thyrotropin-suppressive therapy in patients with well-differentiated thyroid carcinoma]. ( Miyakawa, M, 2007) |
| "Contemporary data on the effect of levothyroxine dose on the occurrence of atrial fibrillation (AF) are lacking, particularly in the older population." | 4.02 | Levothyroxine dose and risk of atrial fibrillation: A nested case-control study. ( Atzema, CL; Austin, PC; Gong, IY; Lega, IC; Lipscombe, LL; Na, Y; Rochon, PA, 2021) |
| "Mendelian randomization analyses for stroke and CAD using genetic instruments associated with normal range thyrotropin (TSH) and free thyroxine levels or Hashimoto's thyroiditis and Graves' disease." | 3.96 | Thyroid Function Affects the Risk of Stroke via Atrial Fibrillation: A Mendelian Randomization Study. ( Chaker, L; Del Greco M, F; Deloukas, P; Kus, A; Marouli, E; Medici, M; Peeters, R; Teumer, A, 2020) |
| "Levothyroxine treatment is common among older adults as is atrial fibrillation (AF), yet less is known about its potential effects on the development of dementia." | 3.96 | Levothyroxine treatment and incident dementia in adults with atrial fibrillation. ( Carlsson, AC; Li, X; Sundquist, J; Sundquist, K; Wändell, P, 2020) |
| "The possible adverse or positive effects of levothyroxine treatment among patients with atrial fibrillation have been debated." | 3.91 | Effect of Levothyroxine Treatment on Incident Dementia in Adults with Atrial Fibrillation and Hypothyroidism. ( Carlsson, AC; Sundquist, J; Sundquist, K; Wändell, P, 2019) |
| "Increased free thyroxine (FT4) and decreased thyrotropin are associated with increased risk of atrial fibrillation (AF) in observational studies, but direct involvement is unclear." | 3.91 | Assessment of the Relationship Between Genetic Determinants of Thyroid Function and Atrial Fibrillation: A Mendelian Randomization Study. ( Albert, CM; Alonso, A; Arking, DE; Benjamin, EJ; Cappola, AR; Chasman, DI; Christophersen, IE; Delgado, G; Dörr, M; Ellervik, C; Ellinor, P; Geelhoed, B; Gudnason, V; Guo, X; Heckbert, S; Homuth, G; Jukema, JW; Kleber, ME; Köttgen, A; Lin, H; Lin, HJ; Lubitz, SA; MacFarlane, P; März, W; Mooijaart, S; Mora, S; Pietzner, M; Psaty, BM; Ridker, PM; Rienstra, M; Roden, D; Roselli, C; Rotter, JI; Selvin, E; Shaffer, C; Shoemaker, MB; Sitlani, CM; Smith, AV; Sotoodehnia, N; Stott, DJ; Taylor, KD; Trompet, S; van der Harst, P; Verweij, N; Völzke, H; Weiss, S, 2019) |
| "Compared to patients only taking l-thyroxine, those using liothyronine had no increased risk of cardiovascular disease [hazard ratio (HR) 1·04; 95% CI 0·70-1·54], atrial fibrillation (HR 0·91: 0·47-1·75), or fractures (HR 0·79: 0·49-1·27) after adjusting for age." | 3.83 | Liothyronine use in a 17 year observational population-based study - the tears study. ( Donnelly, LA; Leese, GP; Soto-Pedre, E, 2016) |
| "A total of 1450 ambulatory community volunteer participants in the Baltimore Longitudinal Study of Aging examined at the NIA Clinical Research Unit in Baltimore, MD, have undergone longitudinal monitoring of serum thyrotropin (TSH) and thyroid hormone (free thyroxine and free triiodothryonine) levels as well as medication use every one to four years, depending on age, between 2003 and 2014." | 3.81 | Thyroid Hormone Therapy and Risk of Thyrotoxicosis in Community-Resident Older Adults: Findings from the Baltimore Longitudinal Study of Aging. ( Chia, CW; Ladenson, PW; Mammen, JS; McGready, J; Oxman, R; Simonsick, EM, 2015) |
| "It has been shown that the concentration of serum free thyroxine (FT(4)) is independently associated with atrial fibrillation (AF), even in euthyroid persons." | 3.76 | High-normal thyroid function and risk of recurrence of atrial fibrillation after catheter ablation. ( Dong, JZ; Hu, FL; Liu, DL; Liu, XH; Liu, XP; Long, DY; Ma, CS; Tang, RB; Wu, JH; Yu, RH, 2010) |
| "We describe the effects of iopanoic acid on daily levels of free triiodothyronine (FT(3)) and free thyroxine (FT(4)) in a patient with progressive type II amiodarone-induced thyrotoxicosis (AIT) who was undergoing thyroidectomy." | 3.74 | Pharmacodynamic effect of iopanoic acid on free T(3) and T(4) levels in amiodarone-induced thyrotoxicosis. ( Falciglia, M; Matrka, L; Nikiforov, Y; Steward, D, 2008) |
| " Sixteen patients (89%) developed hypothyroidism requiring replacement therapy with L-thyroxine." | 3.72 | [Prevention of recurrent amiodarone-induced hyperthyroidism by iodine-131]. ( Arlot, S; Hermida, JS; Jarry, G; Moullart, V; Rey, JL; Schvartz, C; Tcheng, E, 2004) |
| "Twenty patients with thyrotoxic Basedow's disease complicated by atrial fibrillation lasting more than one month despite treatment with antithyroidal drugs were treated with radioiodine supplemented with an antithyroidal drug or inorganic iodine." | 3.68 | Reversion of thyrotoxic atrial fibrillation in hypothyroid state after radioiodine treatment. ( Fukazawa, H; Itagaki, Y; Kaise, K; Kaise, N; Saito, S; Sakurada, T; Yamamoto, M; Yoshida, K; Yoshinaga, K, 1992) |
| "Four patients are described with persistent atrial fibrillation associated with normal plasma total thyroxine (T4) and triiodothyronine (T3) but an absent plasma thyrotrophin (TSH) response to intravenous thyrotrophin releasing hormone (TRH)." | 3.66 | Atrial fibrillation and isolated suppression of the pituitary-thyroid axis: response to specific antithyroid therapy. ( Feek, CM; Forfar, JC; Miller, HC; Toft, AD, 1981) |
| "Serum total thyroxine, triiodothyronine and thyrotropin response to thyrotropin-releasing hormone were measured in 75 consecutive patients presenting to a cardiology clinic with atrial fibrillation with no obvious cardiovascular cause." | 3.66 | Occult thyrotoxicosis: a correctable cause of "idiopathic" atrial fibrillation. ( Forfar, JC; Miller, HC; Toft, AD, 1979) |
| "Subclinical hyperthyroidism has been associated with increased risk of atrial fibrillation and osteoporosis, but the association with cardiovascular disease and death is uncertain." | 2.72 | Decision Making in Subclinical Thyroid Disease. ( Evron, JM; Papaleontiou, M, 2021) |
| "Thyrotropin-secreting pituitary adenomas (TSHomas) are a rare entity, occurring in one per million people." | 2.72 | ENDOCRINE TUMOURS: Thyrotropin-secreting pituitary adenoma: a structured review of 535 adult cases. ( De Block, C; De Herdt, C; Philipse, E, 2021) |
| "Despite clinical practice guidelines for the management of differentiated thyroid cancer (DTC), there are no recommendations on the optimal serum thyrotropin (TSH) concentration to reduce tumor recurrences and improve survival, while ensuring an optimal quality of life with minimal adverse effects." | 2.46 | Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer. ( Biondi, B; Cooper, DS, 2010) |
| "In patients with newly treated hypothyroidism, cardiovascular event rates were similar for generic and brand L-T4." | 1.51 | Comparison of Incident Cardiovascular Event Rates Between Generic and Brand l-Thyroxine for the Treatment of Hypothyroidism. ( Bernet, V; Kusumoto, F; Mwangi, R; Sangaralingham, LR; Smallridge, RC; Van Houten, H, 2019) |
| "In the setting of differentiated thyroid cancer (DTC) management, < 0." | 1.42 | Risk-benefit ratio for TSH- suppressive Levothyroxine therapy in differentiated thyroid cancer. ( Do Cao, C; Wémeau, JL, 2015) |
| "TSH suppression in thyroid cancer is associated with a high prevalence of AF, particularly in older individuals." | 1.38 | Prevalence of atrial fibrillation in patients taking TSH suppression therapy for management of thyroid cancer. ( Abonowara, A; Alqambar, MH; Hart, RD; Imran, SA; O'Connell, CM; Quraishi, A; Rajaraman, MM; Sapp, JL; Saric, A, 2012) |
| "It was shown that patients with CHD, paroxysmal atrial fibrillation and subclinical thyrotoxicosis had T3 and T4 levels 92." | 1.38 | [The influence of subclinical thyroid dysfunction on cardiac hemodynamic and electrophysiological parameters in patients with coronary heart disease and paroxysmal atrial fibrillation]. ( Khodakova, AI; Klimova, SV; Pchelinsteva, SA; Rakhmatullov, AF; Rakhmatullov, FK; Rudakova, LE, 2012) |
| "Hyperthyroidism is a relative uncommon but important cause of atrial fibrillation." | 1.37 | Utility of routine thyroid-stimulating hormone determination in new-onset atrial fibrillation in the ED. ( Buccelletti, F; Carroccia, A; Franceschi, F; Gilardi, E; Marsiliani, D; Silveri, NG, 2011) |
| "Familial thyroid hormone resistance (Refetoff syndrome) was suspected and could be confirmed by detection of a pathogenic mutation within the beta-thyroidhormone receptor gene." | 1.36 | [A 46-year-old patient with atrial fibrillation, elevated thyroid hormones and normal thyrotropine]. ( Gutt, B; Opherk, IV; Schumm-Draeger, PM; Siegmund, T; Volz, S, 2010) |
| " The dangers associated with changing to a preparation with different bioavailability are summarized, noting the particular danger of giving a more active preparation to a patient receiving TSH-suppressive doses of levothyroxine." | 1.33 | New questions regarding bioequivalence of levothyroxine preparations: a clinician's response. ( Green, WL, 2005) |
| "Thyrotoxicosis has been associated with several cardiac complications, including atrial fibrillation (AF), functional cardiomyopathy, and congestive heart failure (CHF)." | 1.29 | Thyrotoxicosis-induced congestive heart failure in an urban hospital. ( Newmark, SR; Wilson, BE, 1994) |
| "Atrial fibrillation (AF) and primary hypothyroidism are most often diagnosed in middle-aged and older dogs of large and giant breeds." | 1.29 | Relationship between atrial fibrillation and primary hypothyroidism in the dog. ( Gerritsen, RJ; Stokhof, AA; van den Brom, WE, 1996) |
| "Hyperthyroidism has been considered to be underdiagnosed as a pathogenetic factor for atrial fibrillation, according to results of thyroliberin stimulation tests." | 1.28 | Thyrotoxic atrial fibrillation: an underdiagnosed or overdiagnosed condition? ( Darpö, B; Fagerberg, B; Lindstedt, G; Lundberg, PA; Nyström, E; Olsson, SB; Sjöström, L; Strömblad, SO, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (15.46) | 18.7374 |
| 1990's | 10 (10.31) | 18.2507 |
| 2000's | 22 (22.68) | 29.6817 |
| 2010's | 38 (39.18) | 24.3611 |
| 2020's | 12 (12.37) | 2.80 |
| Authors | Studies |
|---|---|
| Evron, JM | 1 |
| Papaleontiou, M | 1 |
| Gencer, B | 1 |
| Cappola, AR | 3 |
| Rodondi, N | 3 |
| Collet, TH | 2 |
| Alonso-Ventura, V | 1 |
| Civeira, F | 1 |
| Alvarado-Rosas, A | 1 |
| Lou-Bonafonte, JM | 1 |
| Calmarza, P | 1 |
| Moreno-Franco, B | 1 |
| Andres-Otero, MJ | 1 |
| Calvo-Gracia, F | 1 |
| de Diego-Garcia, P | 1 |
| Laclaustra, M | 1 |
| Buber, I | 1 |
| Eraydin, A | 1 |
| Sevgican, CI | 1 |
| Tekin, I | 1 |
| Kilic, ID | 1 |
| Fenkci, SM | 1 |
| Ettleson, MD | 1 |
| Anderson, JL | 2 |
| Jacobs, V | 1 |
| May, HT | 1 |
| Bair, TL | 1 |
| Benowitz, BA | 1 |
| Lappe, DL | 1 |
| Muhlestein, JB | 1 |
| Knowlton, KU | 1 |
| Bunch, TJ | 1 |
| Marouli, E | 1 |
| Kus, A | 1 |
| Del Greco M, F | 1 |
| Chaker, L | 2 |
| Peeters, R | 1 |
| Teumer, A | 1 |
| Deloukas, P | 1 |
| Medici, M | 2 |
| Öztürk, S | 1 |
| Kayacioglu, I | 1 |
| Sensoz, Y | 1 |
| Özdemir, K | 1 |
| Öztürk, I | 1 |
| Gong, IY | 1 |
| Atzema, CL | 1 |
| Lega, IC | 1 |
| Austin, PC | 1 |
| Na, Y | 1 |
| Rochon, PA | 1 |
| Lipscombe, LL | 1 |
| Kritchevsky, J | 1 |
| Olave, C | 1 |
| Tinkler, S | 1 |
| Tropf, M | 1 |
| Ivester, K | 1 |
| Forsythe, L | 1 |
| Couetil, L | 1 |
| De Herdt, C | 1 |
| Philipse, E | 1 |
| De Block, C | 1 |
| Wang, F | 1 |
| Zhang, SJ | 1 |
| Yao, X | 1 |
| Tian, DM | 1 |
| Zhang, KQ | 1 |
| She, DM | 1 |
| Guo, FF | 1 |
| Zhai, QW | 1 |
| Ying, H | 1 |
| Xue, Y | 1 |
| Wändell, P | 3 |
| Carlsson, AC | 4 |
| Holzmann, MJ | 1 |
| Ärnlöv, J | 1 |
| Sundquist, J | 4 |
| Sundquist, K | 4 |
| Baumgartner, C | 2 |
| da Costa, BR | 1 |
| Feller, M | 1 |
| Floriani, C | 1 |
| Bauer, DC | 1 |
| Heckbert, SR | 1 |
| Ceresini, G | 1 |
| Gussekloo, J | 1 |
| den Elzen, WPJ | 1 |
| Peeters, RP | 3 |
| Luben, R | 1 |
| Völzke, H | 2 |
| Dörr, M | 2 |
| Walsh, JP | 1 |
| Bremner, A | 1 |
| Iacoviello, M | 1 |
| Macfarlane, P | 2 |
| Heeringa, J | 3 |
| Stott, DJ | 2 |
| Westendorp, RGJ | 1 |
| Khaw, KT | 1 |
| Magnani, JW | 1 |
| Aujesky, D | 1 |
| Ellervik, C | 1 |
| Roselli, C | 1 |
| Christophersen, IE | 1 |
| Alonso, A | 1 |
| Pietzner, M | 1 |
| Sitlani, CM | 1 |
| Trompet, S | 1 |
| Arking, DE | 1 |
| Geelhoed, B | 1 |
| Guo, X | 1 |
| Kleber, ME | 1 |
| Lin, HJ | 1 |
| Lin, H | 1 |
| Selvin, E | 1 |
| Shaffer, C | 1 |
| Smith, AV | 1 |
| Verweij, N | 1 |
| Weiss, S | 1 |
| Gudnason, V | 1 |
| Heckbert, S | 1 |
| Mooijaart, S | 1 |
| März, W | 1 |
| Psaty, BM | 1 |
| Ridker, PM | 1 |
| Roden, D | 1 |
| Benjamin, EJ | 2 |
| Delgado, G | 1 |
| Ellinor, P | 1 |
| Homuth, G | 1 |
| Köttgen, A | 1 |
| Jukema, JW | 1 |
| Lubitz, SA | 1 |
| Mora, S | 1 |
| Rienstra, M | 1 |
| Rotter, JI | 1 |
| Shoemaker, MB | 1 |
| Sotoodehnia, N | 1 |
| Taylor, KD | 1 |
| van der Harst, P | 1 |
| Albert, CM | 1 |
| Chasman, DI | 1 |
| Larsson, SC | 1 |
| Allara, E | 1 |
| Mason, AM | 1 |
| Michaëlsson, K | 1 |
| Burgess, S | 1 |
| Smallridge, RC | 1 |
| Sangaralingham, LR | 1 |
| Mwangi, R | 1 |
| Kusumoto, F | 1 |
| Van Houten, H | 1 |
| Bernet, V | 1 |
| Li, X | 1 |
| Blake, RR | 1 |
| Longo, M | 1 |
| Santarelli, G | 1 |
| Liuti, T | 1 |
| Martinez-Pereira LdaVet, Y | 1 |
| Chow, B | 1 |
| French, A | 1 |
| Zhang, Y | 1 |
| Dedkov, EI | 1 |
| Lee, B | 1 |
| Li, Y | 1 |
| Pun, K | 1 |
| Gerdes, AM | 1 |
| He, LR | 1 |
| Qiao, W | 1 |
| Liao, ZX | 1 |
| Komaki, R | 1 |
| Ho, L | 1 |
| Hofstetter, WL | 1 |
| Lin, SH | 1 |
| Goichot, B | 1 |
| Caron, P | 1 |
| Landron, F | 1 |
| Bouée, S | 1 |
| Mammen, JS | 1 |
| McGready, J | 1 |
| Oxman, R | 1 |
| Chia, CW | 1 |
| Ladenson, PW | 1 |
| Simonsick, EM | 1 |
| Dehghan, A | 1 |
| Visser, WE | 1 |
| Hofman, A | 2 |
| Franco, OH | 1 |
| Sousa, PA | 1 |
| Providência, R | 1 |
| Albenque, JP | 1 |
| Khoueiry, Z | 1 |
| Combes, N | 1 |
| Combes, S | 1 |
| Boveda, S | 1 |
| Li, H | 1 |
| Murphy, T | 1 |
| Zhang, L | 1 |
| Huang, B | 1 |
| Veitla, V | 1 |
| Scherlag, BJ | 1 |
| Kem, DC | 1 |
| Yu, X | 1 |
| Do Cao, C | 1 |
| Wémeau, JL | 1 |
| Leese, GP | 1 |
| Soto-Pedre, E | 1 |
| Donnelly, LA | 1 |
| Jakowczuk, M | 1 |
| Zalas, D | 1 |
| Owecki, M | 1 |
| Patanè, S | 1 |
| Marte, F | 1 |
| Sato, H | 1 |
| Miyamoto, Y | 1 |
| Inagaki, M | 1 |
| Kanai, G | 1 |
| Suzuki, H | 1 |
| Tanaka, R | 1 |
| Kakuta, T | 1 |
| Saito, A | 1 |
| Hoogendoorn, EH | 2 |
| van der Deure, WM | 1 |
| Hop, WC | 1 |
| den Heijer, M | 2 |
| Visser, TJ | 1 |
| Witteman, JC | 1 |
| Matrka, L | 1 |
| Steward, D | 1 |
| Falciglia, M | 1 |
| Nikiforov, Y | 1 |
| Gen, R | 1 |
| Akbay, E | 1 |
| Camsari, A | 1 |
| Ozcan, T | 1 |
| Bros, JA | 1 |
| Lluís, PG | 1 |
| Cabot, GL | 1 |
| Pedragós, AC | 1 |
| Opherk, IV | 1 |
| Gutt, B | 1 |
| Volz, S | 1 |
| Siegmund, T | 1 |
| Schumm-Draeger, PM | 1 |
| Brabant, G | 1 |
| Jolobe, O | 1 |
| Biondi, B | 3 |
| Cooper, DS | 2 |
| Belchikov, YG | 1 |
| Marotta, SE | 1 |
| Tang, RB | 1 |
| Liu, DL | 1 |
| Dong, JZ | 1 |
| Liu, XP | 1 |
| Long, DY | 1 |
| Yu, RH | 1 |
| Hu, FL | 1 |
| Wu, JH | 1 |
| Liu, XH | 1 |
| Ma, CS | 1 |
| Buccelletti, F | 1 |
| Carroccia, A | 1 |
| Marsiliani, D | 1 |
| Gilardi, E | 1 |
| Silveri, NG | 1 |
| Franceschi, F | 1 |
| Donangelo, I | 1 |
| Braunstein, GD | 1 |
| Wändell, PE | 1 |
| Johansson, SE | 1 |
| Huang, JH | 1 |
| Lin, YK | 1 |
| Hsieh, MH | 1 |
| Chen, SA | 1 |
| Chen, YJ | 1 |
| Marshall, LL | 1 |
| Bogazzi, F | 1 |
| Tomisti, L | 1 |
| Bartalena, L | 1 |
| Aghini-Lombardi, F | 1 |
| Martino, E | 1 |
| Abonowara, A | 1 |
| Quraishi, A | 1 |
| Sapp, JL | 1 |
| Alqambar, MH | 1 |
| Saric, A | 1 |
| O'Connell, CM | 1 |
| Rajaraman, MM | 1 |
| Hart, RD | 1 |
| Imran, SA | 1 |
| Rakhmatullov, FK | 1 |
| Klimova, SV | 1 |
| Rudakova, LE | 1 |
| Pchelinsteva, SA | 1 |
| Rakhmatullov, AF | 1 |
| Khodakova, AI | 1 |
| Paul, R | 1 |
| Rachmatullov, FK | 1 |
| Bondarenko, LA | 1 |
| Bibarsova, AM | 1 |
| Kapelovich, VIu | 1 |
| Osipova, VV | 1 |
| Karakina, AN | 1 |
| Zinov'eva, EG | 1 |
| Tatarchenko, IP | 1 |
| Cerillo, AG | 1 |
| Bevilacqua, S | 1 |
| Storti, S | 1 |
| Mariani, M | 1 |
| Kallushi, E | 1 |
| Ripoli, A | 1 |
| Clerico, A | 1 |
| Glauber, M | 1 |
| Singer, DE | 1 |
| Bayer, Y | 1 |
| Fasshauer, M | 1 |
| Paschke, R | 1 |
| Hermida, JS | 1 |
| Jarry, G | 1 |
| Tcheng, E | 1 |
| Moullart, V | 1 |
| Arlot, S | 1 |
| Rey, JL | 1 |
| Schvartz, C | 1 |
| Wiersinga, WM | 1 |
| Prummel, MF | 1 |
| Corstens, FH | 1 |
| Hermus, AR | 1 |
| Green, WL | 1 |
| Gammage, MD | 1 |
| Parle, JV | 1 |
| Holder, RL | 1 |
| Roberts, LM | 1 |
| Hobbs, FD | 1 |
| Wilson, S | 1 |
| Sheppard, MC | 1 |
| Franklyn, JA | 1 |
| Batcher, EL | 1 |
| Tang, XC | 1 |
| Singh, BN | 1 |
| Singh, SN | 1 |
| Reda, DJ | 1 |
| Hershman, JM | 1 |
| Miyakawa, M | 1 |
| Stöckli, R | 1 |
| Cobler, JL | 1 |
| Williams, ME | 1 |
| Greenland, P | 1 |
| Anastasiou-Nana, M | 1 |
| Koutras, DA | 1 |
| Levis, G | 1 |
| Souvatzoglou, A | 1 |
| Boukis, MA | 1 |
| Moulopoulos, SD | 1 |
| Agner, T | 1 |
| Almdal, T | 1 |
| Thorsteinsson, B | 1 |
| Agner, E | 1 |
| Forfar, JC | 2 |
| Feek, CM | 1 |
| Miller, HC | 2 |
| Toft, AD | 3 |
| Franklyn, J | 1 |
| Sawin, CT | 1 |
| Geller, A | 1 |
| Wolf, PA | 1 |
| Belanger, AJ | 1 |
| Baker, E | 1 |
| Bacharach, P | 1 |
| Wilson, PW | 1 |
| D'Agostino, RB | 1 |
| Wilson, BE | 1 |
| Newmark, SR | 1 |
| Gerritsen, RJ | 1 |
| van den Brom, WE | 1 |
| Stokhof, AA | 1 |
| Ott, RA | 1 |
| Gutfinger, DE | 1 |
| Miller, MP | 1 |
| Alimadadian, H | 1 |
| Tanner, TM | 1 |
| Woeber, KA | 1 |
| Yeo, PP | 1 |
| Loh, KC | 1 |
| Gangemi, D | 1 |
| Ponzetto, M | 1 |
| Scarafiotti, C | 1 |
| Neirotti, M | 1 |
| Molaschi, M | 1 |
| Fadel, BM | 1 |
| Ellahham, S | 1 |
| Ringel, MD | 1 |
| Lindsay, J | 1 |
| Wartofsky, L | 1 |
| Burman, KD | 1 |
| Yu, YH | 1 |
| Bilezikian, JP | 1 |
| Cattaneo, F | 1 |
| Klein, I | 1 |
| Ojamaa, K | 1 |
| Auer, J | 1 |
| Scheibner, P | 1 |
| Mische, T | 1 |
| Langsteger, W | 1 |
| Eber, O | 1 |
| Eber, B | 1 |
| Papapetrou, PD | 1 |
| Jackson, IM | 1 |
| Symons, C | 1 |
| Myers, A | 1 |
| Kingstone, D | 1 |
| Boss, M | 1 |
| Eraker, SA | 1 |
| Wickamasekaran, R | 1 |
| Goldman, S | 1 |
| Baruch, AL | 1 |
| Davis, C | 1 |
| Hodkinson, HM | 1 |
| Yamamoto, M | 1 |
| Saito, S | 1 |
| Sakurada, T | 1 |
| Yoshida, K | 1 |
| Kaise, K | 1 |
| Kaise, N | 1 |
| Fukazawa, H | 1 |
| Itagaki, Y | 1 |
| Yoshinaga, K | 1 |
| Fagerberg, B | 1 |
| Lindstedt, G | 1 |
| Strömblad, SO | 1 |
| Darpö, B | 1 |
| Nyström, E | 1 |
| Sjöström, L | 1 |
| Lundberg, PA | 1 |
| Olsson, SB | 1 |
| Blacker, C | 1 |
| Fessard, N | 1 |
| Grenier, J | 1 |
| Forette, B | 1 |
| Schlienger, JL | 1 |
| Cherfan, J | 1 |
| Drawin, T | 1 |
| Sacrez, A | 1 |
| Davies, AB | 1 |
| Williams, I | 1 |
| John, R | 1 |
| Hall, R | 1 |
| Scanlon, MF | 1 |
| Daya, H | 1 |
| Arnsdorf, MF | 1 |
| Childers, RW | 1 |
| Lyngborg, K | 1 |
| Jacobsen, JG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Cognitive Functions and Mood During Thyrotropin Suppressive Therapy in Patients With Differentiated Thyroid Carcinoma[NCT02665325] | 100 participants (Anticipated) | Observational | 2016-01-31 | Recruiting | |||
| Desiccated Thyroid Extract Compared to Levothyroxine in the Treatment of Hypothyroidism: A Randomized, Double-blind, Crossover Study.[NCT01739972] | 180 participants (Anticipated) | Interventional | 2012-05-31 | Recruiting | |||
| "Subclinical Hyperthyroidism To Treat or Not to Treat? A Dutch Multicenter Trial"[NCT00151723] | 200 participants (Anticipated) | Interventional | 2004-04-30 | Recruiting | |||
| Effect of Levothyroxine on Serum Adiponectin, Insulin Resistance and Cardiovascular Risk in Patients With Hypothyroidism[NCT02467244] | 120 participants (Actual) | Observational | 2017-02-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
23 reviews available for thyroxine and Atrial Fibrillation
| Article | Year |
|---|---|
Decision Making in Subclinical Thyroid Disease.
Topics: Age Factors; Atrial Fibrillation; Cardiovascular Diseases; Clinical Decision-Making; Cognition Disor | 2021 |
Challenges in the Management of Atrial Fibrillation With Subclinical Hyperthyroidism.
Topics: Age Factors; Atrial Fibrillation; Disease Management; Humans; Hyperthyroidism; Prevalence; Risk Fact | 2021 |
Cardiovascular outcomes in subclinical thyroid disease: an update.
Topics: Atrial Fibrillation; Cardiovascular Diseases; Humans; Hypothyroidism; Middle Aged; Prospective Studi | 2023 |
Efficiency of Thyroid Function Test in the Prediction of Atrial Fibrillation Following Open Heart Surgery.
Topics: Atrial Fibrillation; Cardiac Surgical Procedures; Humans; Prognosis; Thyroid Function Tests; Thyrotr | 2020 |
ENDOCRINE TUMOURS: Thyrotropin-secreting pituitary adenoma: a structured review of 535 adult cases.
Topics: Adenoma; Atrial Fibrillation; Chemotherapy, Adjuvant; Goiter; Gonadotropins, Pituitary; Growth Hormo | 2021 |
Thyroid Function Within the Normal Range, Subclinical Hypothyroidism, and the Risk of Atrial Fibrillation.
Topics: Adult; Aged; Aged, 80 and over; Asymptomatic Diseases; Atrial Fibrillation; Biomarkers; Chi-Square D | 2017 |
Thyroid Function and Dysfunction in Relation to 16 Cardiovascular Diseases.
Topics: Atrial Fibrillation; Cardiovascular Diseases; Databases, Factual; Genetic Predisposition to Disease; | 2019 |
[Primary hypothyroidism: Considerations for a rational use of levothyroxine therapy].
Topics: Adult; Atrial Fibrillation; Autoimmune Diseases; Comorbidity; Contraindications; Dose-Response Relat | 2011 |
[New normal ranges for TSH: when to treat?].
Topics: Antithyroid Agents; Atrial Fibrillation; Cross-Sectional Studies; Humans; Hyperthyroidism; Hypothyro | 2009 |
Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Bone Density; Female; Heart; Heart Rate; Humans; Hyper | 2010 |
Update on subclinical hyperthyroidism.
Topics: Adult; Age Factors; Aged; Atrial Fibrillation; Bone Density; Cognition; Cognition Disorders; Evidenc | 2011 |
Subclinical thyroid disease.
Topics: Atrial Fibrillation; Cardiovascular Diseases; Comorbidity; Diagnosis, Differential; Disease Progress | 2012 |
Gastrointestinal bleeding and possible hypothyroidism.
Topics: Aged, 80 and over; Amiodarone; Anemia; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroid | 2012 |
Amiodarone and the thyroid: a 2012 update.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Hypothyroidism; Thyroxine | 2012 |
Mechanisms in endocrinology: Heart failure and thyroid dysfunction.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Coronary Disease; | 2012 |
[Subclinical hypothyroidism; the start of a clinical trial into the usefulness of treatment with radioactive iodine].
Topics: Atrial Fibrillation; Diagnosis, Differential; Humans; Hypothyroidism; Iodine Radioisotopes; Thyroid | 2004 |
[Effects of thyrotropin-suppressive therapy in patients with well-differentiated thyroid carcinoma].
Topics: Atrial Fibrillation; Chemotherapy, Adjuvant; Humans; Hyperthyroidism; Neoplasm Recurrence, Local; Os | 2007 |
[Subclinical thyroid disease].
Topics: Adult; Age Factors; Aged; Antithyroid Agents; Atrial Fibrillation; Bone Density; Diagnosis, Differen | 2007 |
Subclinical thyroid dysfunction.
Topics: Atrial Fibrillation; Bone Density; Depressive Disorder; Female; Humans; Hypothyroidism; Lipids; Male | 1997 |
Subclinical thyrotoxicosis.
Topics: Atrial Fibrillation; Biomarkers; Bone and Bones; Bone Density; Bone Resorption; Diagnosis, Different | 1998 |
Hyperthyroid heart disease.
Topics: Atrial Fibrillation; Heart; Heart Diseases; Heart Failure; Humans; Hyperthyroidism; Myocardial Contr | 2000 |
Thyroid hormone and the cardiovascular system.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Heart; Heart Diseases | 2001 |
Clinical practice. Subclinical hyperthyroidism.
Topics: Aged; Anticoagulants; Antithyroid Agents; Atrial Fibrillation; Female; Humans; Hyperthyroidism; Meth | 2001 |
2 trials available for thyroxine and Atrial Fibrillation
| Article | Year |
|---|---|
A randomised, controlled trial to determine the effect of levothyroxine on Standardbred racehorses.
Topics: Animals; Atrial Fibrillation; Exercise Test; Heart Rate; Horse Diseases; Horses; Lactic Acid; Physic | 2022 |
Thyroid function abnormalities during amiodarone therapy for persistent atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cohort Studies; Female; Humans; Hyper | 2007 |
72 other studies available for thyroxine and Atrial Fibrillation
| Article | Year |
|---|---|
A Cross-Sectional Study Examining the Parametric Thyroid Feedback Quantile Index and Its Relationship with Metabolic and Cardiovascular Diseases.
Topics: Adult; Atrial Fibrillation; Cardiovascular Diseases; Cross-Sectional Studies; Diabetes Mellitus, Typ | 2022 |
The effects of combination treatment with LT4 and LT3 on diastolic functions and atrial conduction time in LT4-treated women with low T3: a short term follow-up study.
Topics: Adolescent; Adult; Aged; Atrial Fibrillation; Female; Follow-Up Studies; Heart Atria; Humans; Hypoth | 2023 |
Free thyroxine within the normal reference range predicts risk of atrial fibrillation.
Topics: Aged; Atrial Fibrillation; Biomarkers; Databases, Factual; Electronic Health Records; Female; Humans | 2020 |
Thyroid Function Affects the Risk of Stroke via Atrial Fibrillation: A Mendelian Randomization Study.
Topics: Adult; Atrial Fibrillation; Body Mass Index; Coronary Artery Disease; Datasets as Topic; Female; Gra | 2020 |
Levothyroxine dose and risk of atrial fibrillation: A nested case-control study.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Case-Control Studies; Dose-Response Relationship, Drug | 2021 |
Circulating microRNA-1a is a biomarker of Graves' disease patients with atrial fibrillation.
Topics: Adult; Aged; Atrial Fibrillation; Biomarkers; Circulating MicroRNA; Female; Graves Disease; Humans; | 2017 |
Comparison of Mortality and Nonfatal Cardiovascular Events in Adults With Atrial Fibrillation With Versus Without Levothyroxine Treatment.
Topics: Age Factors; Aged; Aged, 80 and over; Atrial Fibrillation; Cause of Death; Female; Follow-Up Studies | 2017 |
Circulating Thyroxine: A Major New Risk Marker for Atherosclerosis?
Topics: Atherosclerosis; Atrial Fibrillation; Humans; Thyroxine | 2017 |
Effect of Levothyroxine Treatment on Incident Dementia in Adults with Atrial Fibrillation and Hypothyroidism.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Dementia; Female; Humans; Hypothyroidism; Male; Middle | 2019 |
Assessment of the Relationship Between Genetic Determinants of Thyroid Function and Atrial Fibrillation: A Mendelian Randomization Study.
Topics: Aged; Atrial Fibrillation; Female; Genome-Wide Association Study; Humans; Hyperthyroidism; Hypothyro | 2019 |
Comparison of Incident Cardiovascular Event Rates Between Generic and Brand l-Thyroxine for the Treatment of Hypothyroidism.
Topics: Adult; Aged; Atrial Fibrillation; Drugs, Generic; Female; Humans; Hypothyroidism; Insurance Claim Re | 2019 |
Levothyroxine treatment and incident dementia in adults with atrial fibrillation.
Topics: Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Case-Control Studies; Comorbidity; Cross-Sectio | 2020 |
Coronary arteriovenous malformation in a dog with a complex arrhythmia and hypothyroidism.
Topics: Animals; Arrhythmias, Cardiac; Arteriovenous Malformations; Atrial Fibrillation; Coronary Vessel Ano | 2019 |
Conversion of atrial fibrillation after levothyroxine in a dog with hypothyroidism and arterial thromboembolism.
Topics: Animals; Atrial Fibrillation; Dog Diseases; Dogs; Electrocardiography; Female; Hypothyroidism; Throm | 2014 |
Thyroid hormone replacement therapy attenuates atrial remodeling and reduces atrial fibrillation inducibility in a rat myocardial infarction-heart failure model.
Topics: Animals; Atrial Fibrillation; Atrial Remodeling; Disease Models, Animal; Electrocardiography; Female | 2014 |
Impact of comorbidities and use of common medications on cancer and non-cancer specific survival in esophageal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Anti-Inflammatory Agents, Non-Ster | 2015 |
Clinical presentation of hyperthyroidism in a large representative sample of outpatients in France: relationships with age, aetiology and hormonal parameters.
Topics: Adenoma; Adult; Age Factors; Aged; Atrial Fibrillation; Chi-Square Distribution; Female; France; Goi | 2016 |
Thyroid Hormone Therapy and Risk of Thyrotoxicosis in Community-Resident Older Adults: Findings from the Baltimore Longitudinal Study of Aging.
Topics: Aged; Aged, 80 and over; Aging; Atrial Fibrillation; Baltimore; Bone Density; Ethnicity; Female; Hea | 2015 |
Normal Thyroid Function and the Risk of Atrial Fibrillation: the Rotterdam Study.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Female; Humans; Incidence; Male; Middle Aged; Prevalen | 2015 |
Impact of Free Thyroxine on the Outcomes of Left Atrial Ablation Procedures.
Topics: Atrial Fibrillation; Biomarkers; Catheter Ablation; Catheter-Related Infections; Female; Follow-Up S | 2015 |
β1-Adrenergic and M2 Muscarinic Autoantibodies and Thyroid Hormone Facilitate Induction of Atrial Fibrillation in Male Rabbits.
Topics: Adrenergic beta-1 Receptor Agonists; Animals; Antigens; Atrial Fibrillation; Autoantibodies; Coronar | 2016 |
Risk-benefit ratio for TSH- suppressive Levothyroxine therapy in differentiated thyroid cancer.
Topics: Aged; Atrial Fibrillation; Bone Diseases; Cardiovascular Diseases; Female; Humans; Hyperthyroidism; | 2015 |
Liothyronine use in a 17 year observational population-based study - the tears study.
Topics: Antipsychotic Agents; Atrial Fibrillation; Cardiovascular Diseases; Cohort Studies; Fractures, Bone; | 2016 |
Permanent atrial fibrillation in heart failure patients as another condition with increased reverse triiodothyronine concentration.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Case-Control Studies; Cohort Studies; Female; Heart Fa | 2016 |
Acute myocardial infarction during l-thyroxine therapy in a patient with intermittent changing axis deviation, permanent atrial fibrillation and without significant coronary stenoses.
Topics: Atrial Fibrillation; Coronary Vessels; Electrocardiography; Female; Humans; Middle Aged; Myocardial | 2010 |
Atrial fibrillation induced by post-parathyroidectomy transient thyrotoxicosis.
Topics: Atrial Fibrillation; Female; Humans; Hyperparathyroidism, Secondary; Middle Aged; Parathyroidectomy; | 2008 |
High-normal thyroid function and risk of atrial fibrillation: the Rotterdam study.
Topics: Aged; Atrial Fibrillation; Female; Heart Rate; Humans; Hyperthyroidism; Male; Proportional Hazards M | 2008 |
Pharmacodynamic effect of iopanoic acid on free T(3) and T(4) levels in amiodarone-induced thyrotoxicosis.
Topics: Amiodarone; Atrial Fibrillation; Contrast Media; Humans; Iopanoic Acid; Male; Middle Aged; Thyroidec | 2008 |
P-wave dispersion in endogenous and exogenous subclinical hyperthyroidism.
Topics: Adenocarcinoma, Follicular; Adenoma; Atrial Fibrillation; Carcinoma, Papillary; Electrocardiography; | 2010 |
[A 46-year-old patient with atrial fibrillation, elevated thyroid hormones and normal thyrotropine].
Topics: Atrial Fibrillation; Diagnosis, Differential; Humans; Male; Middle Aged; Thyroid Hormone Resistance | 2010 |
The oldest old subclinically hypothyroid subjects with pre-existing atrial fibrillation might not benefit from replacement therapy.
Topics: Aged, 80 and over; Atrial Fibrillation; Heart Failure; Hormone Replacement Therapy; Humans; Hypothyr | 2010 |
Heparin management in a patient with thyroid storm.
Topics: Adult; Antithrombin III Deficiency; Atrial Fibrillation; Factor VIII; Female; Heparin; Humans; Throm | 2010 |
High-normal thyroid function and risk of recurrence of atrial fibrillation after catheter ablation.
Topics: Adult; Aged; Atrial Fibrillation; Catheter Ablation; Female; Follow-Up Studies; Humans; Male; Middle | 2010 |
Utility of routine thyroid-stimulating hormone determination in new-onset atrial fibrillation in the ED.
Topics: Aged; Atrial Fibrillation; Chi-Square Distribution; Confidence Intervals; Cross-Sectional Studies; E | 2011 |
Total mortality among levothyroxine-treated women with atrial fibrillation in Swedish primary health care.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Female; Humans; Hypothyroidism; Middle Aged; Primary H | 2011 |
Thyroxine monotherapy without amiodarone enhances atrial fibrillation recurrences in amiodarone-induced hypothyroidism.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Therapy, Comb | 2011 |
Prevalence of atrial fibrillation in patients taking TSH suppression therapy for management of thyroid cancer.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Atrial Fibrillation; Cross-Sectional Studie | 2012 |
[The influence of subclinical thyroid dysfunction on cardiac hemodynamic and electrophysiological parameters in patients with coronary heart disease and paroxysmal atrial fibrillation].
Topics: Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Disease; Electrophysiological Phenomena | 2012 |
[Bleeding problems of a patient with hypothyroidism].
Topics: Aged; Anemia; Anticoagulants; Antifungal Agents; Atrial Fibrillation; Drug Interactions; Ecchymosis; | 2002 |
[Hemodynamics, electrophysiological parameters of the heart and differential therapy of attacks of atrial fibrillation in patients with subclinical thyroid dysfunction].
Topics: Adult; Anti-Arrhythmia Agents; Antithyroid Agents; Atrial Fibrillation; Data Interpretation, Statist | 2003 |
Free triiodothyronine: a novel predictor of postoperative atrial fibrillation.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Atrial Fibrillation; Biomarkers; Coronary Arte | 2003 |
A 60-year-old woman with atrial fibrillation.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Anticoagulants; Antihypertensive Agents; Atrial | 2003 |
The novel missense mutation methionine 442 threonine in the thyroid hormone receptor beta causes thyroid hormone resistance: a case report.
Topics: Atrial Fibrillation; Goiter, Nodular; Humans; Male; Methionine; Middle Aged; Mutation, Missense; Ped | 2004 |
[Prevention of recurrent amiodarone-induced hyperthyroidism by iodine-131].
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Hea | 2004 |
New questions regarding bioequivalence of levothyroxine preparations: a clinician's response.
Topics: Area Under Curve; Atrial Fibrillation; Biological Availability; Biopharmaceutics; Chemistry, Pharmac | 2005 |
Association between serum free thyroxine concentration and atrial fibrillation.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Cohort Studies; Electrocardiography; Female; Humans; M | 2007 |
Thyrotoxicosis in institutionalized elderly patients with atrial fibrillation.
Topics: Aged; Atrial Fibrillation; Female; Hospitals, Chronic Disease; Humans; Hyperthyroidism; Male; New Yo | 1984 |
The correlation of serum amiodarone levels with abnormalities in the metabolism of thyroxine.
Topics: Aged; Amiodarone; Atrial Fibrillation; Benzofurans; Female; Humans; Male; Middle Aged; Thyrotropin; | 1984 |
A reevaluation of atrial fibrillation in thyrotoxicosis.
Topics: Adenoma; Adolescent; Adult; Aged; Atrial Fibrillation; Female; Humans; Hyperthyroidism; Male; Middle | 1984 |
Atrial fibrillation and isolated suppression of the pituitary-thyroid axis: response to specific antithyroid therapy.
Topics: Atrial Fibrillation; Electric Countershock; Humans; Hyperthyroidism; Thyrotropin; Thyrotropin-Releas | 1981 |
'Subclinical hypothyroidism': to treat or not to treat, that is the question.
Topics: Atrial Fibrillation; Coronary Disease; Humans; Hypothyroidism; Lipids; Patient Selection; Thyrotropi | 1995 |
Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons.
Topics: Age Factors; Aged; Atrial Fibrillation; Confidence Intervals; Female; Follow-Up Studies; Humans; Hyp | 1994 |
Thyrotoxicosis-induced congestive heart failure in an urban hospital.
Topics: Adult; Atrial Fibrillation; Female; Heart Failure; Hemodynamics; Hospitals, Urban; Humans; Male; Mid | 1994 |
Relationship between atrial fibrillation and primary hypothyroidism in the dog.
Topics: Animals; Atrial Fibrillation; Cardiovascular Physiological Phenomena; Cardiovascular System; Dog Dis | 1996 |
Rapid recovery after coronary artery bypass grafting: is the elderly patient eligible?
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiopulmonary Bypass; Case-Control Studies; Con | 1997 |
Atrial fibrillation and thyroid function in elderly hospitalized subjects.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Female; Hospitalization; Humans; Hyperthyroidism; Male | 1999 |
Tachycardia-induced cardiomyopathy secondary to thyrotoxicosis: a young man with previously unrecognized Graves' disease.
Topics: Adult; Atrial Fibrillation; Cardiomyopathy, Dilated; Echocardiography; Electrocardiography; Graves D | 2000 |
Type II amiodarone-induced thyrotoxicosis and concomitant papillary cancer of the thyroid.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Carcinoma, Papillary; Cardiomyopathy, | 2000 |
Subclinical hyperthyroidism as a risk factor for atrial fibrillation.
Topics: Atrial Fibrillation; Comorbidity; Humans; Hyperthyroidism; Middle Aged; Risk Factors; Thyrotropin; T | 2001 |
Thyrotoxicosis due to "silent" thyroiditis.
Topics: Adult; Atrial Fibrillation; Circadian Rhythm; Female; Goiter; Humans; Hyperthyroidism; Iodine Radioi | 1975 |
Response to thyrotrophin-releasing hormone in atrial dysrhythmias.
Topics: Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Autoantibodies; Coronary Disease; Female; He | 1978 |
Occult thyrotoxicosis: a correctable cause of "idiopathic" atrial fibrillation.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Carbimazole; Female; Heart Failure; Humans; Hyperthyroidi | 1979 |
Complete heart block with hyperthyroidism.
Topics: Adult; Atrial Fibrillation; Electrocardiography; Female; Graves Disease; Heart Block; Humans; Hypoth | 1978 |
Causes of high free-thyroxine index values in sick euthyroid elderly patients.
Topics: Atrial Fibrillation; Digitalis Glycosides; Disease; Diuretics; Drug-Related Side Effects and Adverse | 1976 |
Reversion of thyrotoxic atrial fibrillation in hypothyroid state after radioiodine treatment.
Topics: Adult; Atrial Fibrillation; Autoantibodies; Female; Graves Disease; Humans; Hypothyroidism; Iodine; | 1992 |
Thyrotoxic atrial fibrillation: an underdiagnosed or overdiagnosed condition?
Topics: Aged; Atrial Fibrillation; Female; Humans; Hyperthyroidism; Immunoenzyme Techniques; Male; Middle Ag | 1990 |
[Thyroid function in normal aged subjects or with auricular fibrillation].
Topics: Aged; Aged, 80 and over; Aging; Atrial Fibrillation; Female; Humans; Male; Middle Aged; Thyroid Glan | 1989 |
[Systematic ultrasensitive determination of thyroid-stimulating hormone in 50 cases of atrial fibrillation].
Topics: Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Female; Humans; Hyperthyroidism; Male; Middle A | 1988 |
Diagnostic value of thyrotrophin releasing hormone tests in elderly patients with atrial fibrillation.
Topics: Aged; Atrial Fibrillation; Female; Humans; Hyperthyroidism; Male; Prospective Studies; Thyrotropin; | 1985 |
Hyperthyroidism causing atrial fibrillation in a young man.
Topics: Adult; Antithyroid Agents; Atrial Fibrillation; Electrocardiography; Humans; Hyperthyroidism; Male; | 1966 |
Atrial electrophysiology in experimental hyperthyroidism in rabbits.
Topics: Animals; Atrial Fibrillation; Atropine; Electrophysiology; Heart Atria; Hyperthyroidism; Perfusion; | 1970 |
Intractable paroxysmal tachycardia in thyrotoxicosis simulating myocardial infarction.
Topics: Angina Pectoris; Atrial Fibrillation; Bradycardia; Cardiac Catheterization; Diagnosis, Differential; | 1972 |